Cargando…
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
For over a century, inactivated or attenuated bacteria have been employed in the clinic as immunotherapies to treat cancer, starting with the Coley's vaccines in the 19th century and leading to the currently approved bacillus Calmette-Guérin vaccine for bladder cancer. While effective, the infl...
Autores principales: | Wood, Laurence M., Paterson, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026700/ https://www.ncbi.nlm.nih.gov/pubmed/24860789 http://dx.doi.org/10.3389/fcimb.2014.00051 |
Ejemplares similares
-
Listeria monocytogenes: a promising vector for tumor immunotherapy
por: Ding, Yi-Dan, et al.
Publicado: (2023) -
Listeria monocytogenes as a Vector for Cancer Immunotherapy
por: Leitão, Jorge H.
Publicado: (2020) -
Attenuated Listeria monocytogenes as a Vaccine Vector for the Delivery of OMPW, the Outer Membrane Protein of Aeromonas hydrophila
por: Zeng, Haijuan, et al.
Publicado: (2020) -
Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes
por: Guirnalda, Patrick, et al.
Publicado: (2013) -
Chitin Attenuates Expression of Listeria monocytogenes Virulence Genes in vitro
por: Villoria Recio, Miguel, et al.
Publicado: (2020)